Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Genetic determinants of hair color and Parkinson's disease risk.

Gao X, Simon KC, Han J, Schwarzschild MA, Ascherio A.

Ann Neurol. 2009 Jan;65(1):76-82. doi: 10.1002/ana.21535.

2.

p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants.

Stefanaki I, Stratigos AJ, Dimisianos G, Nikolaou V, Papadopoulos O, Polydorou D, Gogas H, Tsoutsos D, Panagiotou P, Kanavakis E, Antoniou C, Katsambas AD.

Br J Dermatol. 2007 Feb;156(2):357-62.

PMID:
17223878
3.

Interaction between p53 codon 72 polymorphism and melanocortin 1 receptor variants on suntan response and cutaneous melanoma risk.

Nan H, Qureshi AA, Hunter DJ, Han J.

Br J Dermatol. 2008 Aug;159(2):314-21. doi: 10.1111/j.1365-2133.2008.08624.x. Epub 2008 May 28.

4.

Family history of melanoma and Parkinson disease risk.

Gao X, Simon KC, Han J, Schwarzschild MA, Ascherio A.

Neurology. 2009 Oct 20;73(16):1286-91. doi: 10.1212/WNL.0b013e3181bd13a1.

5.

Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color.

Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens M, Bergman W, Willemze R, Bavinck JN.

J Invest Dermatol. 2001 Aug;117(2):294-300.

6.

Melanocortin 1 receptor variants and skin cancer risk.

Han J, Kraft P, Colditz GA, Wong J, Hunter DJ.

Int J Cancer. 2006 Oct 15;119(8):1976-84.

7.

The melanocortin 1 receptor (Mc1r) variants do not account for the co-occurrence of Parkinson's disease and malignant melanoma.

Elincx-Benizri S, Inzelberg R, Greenbaum L, Cohen OS, Yahalom G, Laitman Y, Djaldetti R, Orlev Y, Scope A, Azizi E, Friedman E, Hassin-Baer S.

J Mol Neurosci. 2014 Dec;54(4):820-5. doi: 10.1007/s12031-014-0425-1. Epub 2014 Oct 5.

PMID:
25284244
8.

Calcium channel blocker use and risk of Parkinson's disease.

Simon KC, Gao X, Chen H, Schwarzschild MA, Ascherio A.

Mov Disord. 2010 Sep 15;25(12):1818-22. doi: 10.1002/mds.23191.

9.

Dermoscopic features of melanomas associated with MC1R variants in Spanish CDKN2A mutation carriers.

Cuéllar F, Puig S, Kolm I, Puig-Butille J, Zaballos P, Martí-Laborda R, Badenas C, Malvehy J.

Br J Dermatol. 2009 Jan;160(1):48-53. doi: 10.1111/j.1365-2133.2008.08826.x. Epub 2008 Sep 15.

PMID:
18795926
10.

The role of melanocortin-1 receptor polymorphism in skin cancer risk phenotypes.

Sturm RA, Duffy DL, Box NF, Chen W, Smit DJ, Brown DL, Stow JL, Leonard JH, Martin NG.

Pigment Cell Res. 2003 Jun;16(3):266-72. Review.

PMID:
12753400
11.

Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis.

Dwyer T, van der Mei I, Ponsonby AL, Taylor BV, Stankovich J, McKay JD, Thomson RJ, Polanowski AM, Dickinson JL.

Neurology. 2008 Aug 19;71(8):583-9. doi: 10.1212/01.wnl.0000323928.57408.93.

PMID:
18711112
12.

Interactive effects of MC1R and OCA2 on melanoma risk phenotypes.

Duffy DL, Box NF, Chen W, Palmer JS, Montgomery GW, James MR, Hayward NK, Martin NG, Sturm RA.

Hum Mol Genet. 2004 Feb 15;13(4):447-61. Epub 2004 Jan 6.

PMID:
14709592
13.

Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair.

Bastiaens MT, ter Huurne JA, Kielich C, Gruis NA, Westendorp RG, Vermeer BJ, Bavinck JN; Leiden Skin Cancer Study Team.

Am J Hum Genet. 2001 Apr;68(4):884-94. Epub 2001 Mar 16.

14.

A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women.

Veierød MB, Weiderpass E, Thörn M, Hansson J, Lund E, Armstrong B, Adami HO.

J Natl Cancer Inst. 2003 Oct 15;95(20):1530-8.

PMID:
14559875
15.

Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype?

Palmer JS, Duffy DL, Box NF, Aitken JF, O'Gorman LE, Green AC, Hayward NK, Martin NG, Sturm RA.

Am J Hum Genet. 2000 Jan;66(1):176-86.

16.

Model-based prediction of human hair color using DNA variants.

Branicki W, Liu F, van Duijn K, Draus-Barini J, Pośpiech E, Walsh S, Kupiec T, Wojas-Pelc A, Kayser M.

Hum Genet. 2011 Apr;129(4):443-54. doi: 10.1007/s00439-010-0939-8. Epub 2011 Jan 4.

17.

Spectrophotometric methods for quantifying pigmentation in human hair-influence of MC1R genotype and environment.

Shekar SN, Duffy DL, Frudakis T, Montgomery GW, James MR, Sturm RA, Martin NG.

Photochem Photobiol. 2008 May-Jun;84(3):719-26. doi: 10.1111/j.1751-1097.2007.00237.x.

PMID:
18435620
18.

Main pigmentary features and melanocortin 1 receptor (MC1R) gene polymorphisms in the population of the Canary Islands.

de-Misa RF, Pérez-Méndez LI, Hernández-Jiménez JG, Rodríguez Mdel C, Vilar MC, Suárez J, Claveríe-Martín F.

Int J Dermatol. 2008 Aug;47(8):806-11. doi: 10.1111/j.1365-4632.2008.03680.x.

PMID:
18717860
19.

Use of ibuprofen and risk of Parkinson disease.

Gao X, Chen H, Schwarzschild MA, Ascherio A.

Neurology. 2011 Mar 8;76(10):863-9. doi: 10.1212/WNL.0b013e31820f2d79. Epub 2011 Mar 2.

20.

Prospective study of statin use and risk of Parkinson disease.

Gao X, Simon KC, Schwarzschild MA, Ascherio A.

Arch Neurol. 2012 Mar;69(3):380-4. doi: 10.1001/archneurol.2011.1060.

Supplemental Content

Support Center